ArticleWorld journal of microbiology & biotechnology2026
Effective degradation of aflatoxin B
Article in World journal of microbiology & biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Laccase has great potential for bioremediation, as it oxidizes both non-phenolic and phenolic substrates. In this work, we recombinantly produced the laccase enzyme from Heyndrickxia shackletonii using a combinative strategy of codon and induction optimization. The enzyme produced was purified. Afterward, the biochemical characteristics against the degradation of aflatoxin B1 (AFB1) and zearalenone (ZEN) were presented. The observed H. shackletonii Laccase-gene size was 1533 bp, and the purified enzyme’s molecular weight was estimated to be 56.7 kDa. The enzyme’s degradation potential against AFB1 and ZEN was 95.84% and 97.51%, respectively, after 24 h. The optimum pH for both AFB1 and ZEN was 8. Besides, the optimal temperatures were 40 °C and 55 °C for AFB1 and ZEN, respectively. Notably, the enzyme degraded AFB1 and ZEN simultaneously within 24 h, achieving degradation rates of 97.51% and 96.97%, respectively. Moreover, the study analyzed the storage stability of the enzyme; the HeshLac enzyme remained stable for 60 days at -20 °C and 4 °C, suggesting these are preferred storage conditions. The study also assessed the toxicity of the mycotoxins in zebrafish larvae, where noticeable developmental malformations were observed at the following concentrations: 0.1 µg/mL - AFB1 and 2 µg/mL - ZEN. Nonetheless, no or little changes were observed in the control. This study contributes to the knowledge of mycotoxin bioremediation, and the results are promising for decontaminating AFB1 and ZEN in the food or feed industry.
Indexed as
Identifiers
41963702What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.